The integration of all three pathways is proposed to create a complementary pharmacological profile: appetite suppression and improved insulin secretion from GLP-1 and GIP agonism, combined with enhanced energy expenditure and hepatic lipid metabolism from glucagon receptor activation
You should not feel too sick to eat, work, exercise, or function normally
About Press Copyright Contact us Creators Advertise Developers Impressum Cancel Memberships Terms Privacy Policy & Safety How YouTube works Test new features 2026 Google LLC
Available from: Balaban DH, McNamara S, Wallman K, et al
Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique
All of those 3 things are done by GLP-1 and this is a version of GLP-1